Volume 18, Issue 6, Pages 530-538 (June 2019) Safety and efficacy of co-careldopa as an add-on therapy to occupational and physical therapy in patients after stroke (DARS): a randomised, double-blind, placebo-controlled trial Prof Gary A Ford, FRCP, Bipin B Bhakta, FRCP, Alastair Cozens, MD, Suzanne Hartley, MSc, Ivana Holloway, MSc, David Meads, PhD, John Pearn, MD, Sharon Ruddock, BSc, Catherine M Sackley, PhD, Eirini-Christina Saloniki, PhD, Gillian Santorelli, MSc, Marion F Walker, PhD, Amanda J Farrin, MSc The Lancet Neurology Volume 18, Issue 6, Pages 530-538 (June 2019) DOI: 10.1016/S1474-4422(19)30147-4 Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions
Figure Trial profile *Categories are not mutually exclusive —ie, some patients had more than one exclusion criteria. †Initial screening categories. The Lancet Neurology 2019 18, 530-538DOI: (10.1016/S1474-4422(19)30147-4) Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions